Blog

The expectation of the first interest rate cut in 2025 has skyrocketed after the release of tepid nonfarm payrolls data for August. The addition of a mere 22,000 jobs last month was neither too hot

Intuit Inc. INTU is accelerating its transformation into an AI-first financial technology company, embedding artificial intelligence across TurboTax, QuickBooks, Credit Karma, and Mailchimp to drive

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 9th:

Futu Holdings Limited FUTU: This digitalized securities brokerage and wealth

Sonoco Products Company SON announced that it has inked a definitive agreement with Arsenal Capital Partners to sell the ThermoSafe business unit. This move is in sync with SON’s portfolio

For Immediate Release

Chicago, IL – September 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Schrodinger, Inc. (SDGR) closed the last trading session at $19.44, gaining 4.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

The price trend for CorMedix (CRMD) has been bearish lately and the stock has lost 14% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that

Sezzle Inc. (SEZL) closed the last trading session at $88, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

Astria Therapeutics, Inc. (ATXS) closed the last trading session at $7.43, gaining 11.2% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Shares of Carpenter Technology (CRS) have gained 1.4% over the past four weeks to close the last trading session at $251.88, but there could still be a solid upside left in the stock if short-term

Shares of Sionna Therapeutics, Inc. (SION) have gained 7.9% over the past four weeks to close the last trading session at $21.62, but there could still be a solid upside left in the stock if

DiaMedica Therapeutics, Inc. (DMAC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DMAC's 50-day simple moving average

Wall Street closed in the green yesterday, with all three major indexes inching higher. The Nasdaq Composite gained 0.45% to reach a record 21,798.70, while the S&P 500 added 0.21% to end at

UnitedHealth Group Incorporated UNH is set to reaffirm its 2025 adjusted EPS outlook in upcoming meetings with investors and analysts, even as the recent Amedisys acquisition is expected to be

For Immediate Release

Chicago, IL – September 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and

Encompass Health Corporation EHC is proving that smart expansion and operational discipline can deliver meaningful results. Fueled by an aging population and growing demand for inpatient

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service